Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 |
|---|---|---|---|---|---|---|
| Revenue | 373M | 359M | 333M | 294M | 289M | 263M |
| Cost of revenue | 136M | 128M | 123M | 111M | 110M | 105M |
| Gross profit | 237M | 232M | 210M | 183M | 179M | 158M |
| Research and development | 88M | 83M | 78M | 73M | 70M | 69M |
| Selling, general and administrative | 50M | 48M | 48M | 48M | 42M | 43M |
| Operating expenses | 206M | 193M | 191M | 178M | 167M | 163M |
| Operating income | 31M | 38M | 18M | 4M | 12M | −5M |
| Pre-tax income | 20M | 75M | 25M | 49M | −43M | 3M |
| Income tax | 3M | 14M | −7M | 3M | −6M | −6M |
| Net income | 16M | 60M | 31M | 46M | −37M | 9M |
| Earnings per share | 0.20 | 0.71 | 0.37 | 0.55 | −0.45 | 0.11 |
| Earnings per share, diluted | 0.19 | 0.70 | 0.36 | 0.54 | −0.45 | 0.11 |
| Weighted average shares | 84M | 85M | 85M | 84M | 84M | 83M |
| Weighted average shares, diluted | 85M | 86M | 86M | 86M | 84M | 86M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 295M | 408M | 492M | 698M | 510M | 699M | 825M | 549M |
| Short-term investments | 455M | 511M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | −67M | — | — | −62M |
| Depreciation and amortisation | — | — | 6M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 520M |
| 452M |
| 410M |
| 471M |
| 515M |
| 456M |
| Receivables | 139M | 163M | 95M | 141M | 147M | 123M | 97M | 137M |
| Current assets | 1.22B | 1.35B | 1.36B | 1.51B | 1.31B | 1.48B | 1.64B | 1.30B |
| Property, plant and equipment | 67M | 65M | 65M | 60M | 56M | 54M | 55M | 55M |
| Goodwill | 421M | 422M | 394M | 394M | 394M | 372M | 372M | 372M |
| Total assets | 2.54B | 2.69B | 2.64B | 2.72B | 2.49B | 2.54B | 2.60B | 2.23B |
| Current liabilities | 497M | 459M | 390M | 545M | 406M | 559M | 615M | 838M |
| Total liabilities | 1.22B | 1.18B | 1.11B | 1.26B | 1.13B | 1.27B | 1.33B | 884M |
| Equity | 1.32B | 1.51B | 1.53B | 1.46B | 1.36B | 1.27B | 1.27B | 1.34B |
| Shares outstanding | — | — | — | 85M | — | — | — | 83M |
| Shares issued | — | — | — | 85M | — | — | — | 83M |
| — |
| 6M |
| Share-based compensation | 45M | 47M | 43M | 40M | 41M | 38M |
| Capital expenditure | — | — | 5M | — | — | 843,000 |
| Investing cash flow | — | — | −139M | — | — | −78M |
| Financing cash flow | — | — | 413,000 | — | — | 416M |